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Rhabdomyosarcoma (RMS), which was first 
described by Weber in 1854, is a malignant soft 
tissue neoplasm of skeletal muscle origin. It ac-
counts for 6% of all malignancies in children un-
der 15 years of age.1 The most commonly affected 
areas are the head and neck region, genitourinary 
tract, retroperitonium, and, to a lesser extent, the 
extremities.2 The head and neck RMSs are ana-
tomically divided into 2 categories: parameningeal 
(including RMS of the nose, nasopharynx, parana-
sal sinuses, middle ear, mastoid, infratemporal 
fossa, and pterygopalatine fossa) and nonparame-
ningeal (including RMS of the scalp, orbit, parotid 
gland, oral cavity, oropharynx, and larynx). RMS of 
the oral cavity accounts for 10–12% of all the head 
and neck RMS cases.3
Clinically, the manifestations of RMS may vary 
from a small cutaneous nodule on the face to an 
extensive fast-growing facial swelling, which may 
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be painless or occasionally associated with pain, 
trismus, paresthesia, facial palsy, and nasal dis-
charge.1,4
On the basis of the histological findings, 4 broad 
subtypes of RMS have been identified: botryoid and 
spindle cell RMS, embryonal RMS, alveolar RMS, 
and undifferentiated RMS.5,6 The histogenesis of 
RMS is still unclear, but the most widely accepted 
hypothesis is that RMS arises due to proliferation 
of embryonic mesenchymal tissue.7
In this report, we present a case of oral RMS 
arising within the left cheek mucosa and involv-
ing the mandibular bone in a 13-year-old girl, and 
we describe the clinical, radiological, histopatho-
logical, and immunohistochemical features of this 
RMS.
cAsE rEPort
A 13-year old girl was referred to our institu-
tion in August 2006 for the investigation of pain-
ful swelling in her mouth. On history taking, her 
parents reported that the disease had started as 
a painless swelling in May 2006, and that she had 
received oral and parenteral antibiotics for the 
past 4 months; however, the treatments were in-
effective, and she was therefore referred to us. 
Written informed consent was obtained from her 
parent for further investigations.
Clinical examination showed severe facial 
asymmetry. A large, firm, and tender swelling 
was noted on the left cheek and it caused pain. 
The skin had appeared stretched and inflamed. 
The opening of the mouth was partly restricted. 
Intraoral examination revealed an extensive mass 
involving the buccal mucosa (Figure 1). Magnetic 
resonance imaging (MRI) showed an infiltrative 
large soft tissue lesion in the maxillary sinus, in-
fraorbitary space, pterygopalatine fossa, pterygoid 
plates, and the ramus, which caused displace-
ment of the adjacent structures (Figure 2). An 
incisional biopsy was made. Histological exami-
nation of the specimen showed clusters of small 
round cells with hyper chromatic nuclei and eo-
sinophilic cytoplasm separated by fibrovascular 
septae (Figure 3). The morphologic features of the 
cells indicated a differential diagnosis compris-
ing RMS, Ewing’s sarcoma, malignant melanoma, 
and an epithelial tumor. The neoplastic cells were 
strongly positive for vimentin, desmin, myoglobin, 
and muscle specific-actin (Figure 4) and negative 
for CD99, chromogranin, S 100, HMB 45, EMA, and 
Pan CK. After performing the standard diagnos-
tic work-up, the tumor was diagnosed as alveolar 
RMS. She was referred to the Pediatric Oncology 
Department, and the proposed treatment plan 
was a combination of chemotherapy, including ifo
sfamid+vincristine+actinomycine-D (IVA regimen) 
and Mesna, and radiotherapy. Although the tumor 
showed dramatic regression after the initial 12 
weeks of chemotherapy, the patient’s parents re-
fused external beam radiation therapy. During the 
post-chemotherapy radiographic evaluation, the 
tumor was found to have regressed. However, af-
ter 6 months, she experienced an increase in pain 
and mass localization, limitations in temporoman-
dibular articulation, and loss in weight; therefore, 
she reconsulted the Oncology Clinic. Surprisingly, 
the tumor was found to have rapidly increased in 
size, almost reaching the pretreatment size, indi-
cating the reversal of the effects of chemotherapy. 
Owing to this development, she was administered 
chemotherapy with carboplatin+epirubisin+vincris
tine for 8 weeks. Following the completion of che-
motherapy, she was treated with external beam 
radiation therapy (5,400 cGY) for 8 weeks. Despite 
the treatment, the tumor continued to increase in 
size, and she died 2 years after the initial treat-
ment.
dIscussIon
After neuroblastoma and Wilms tumor, RMS 
is the third most common extracranial malignant 
tumor that affects children. Of all soft tissue sar-
comas, RMS accounts for only 2–5% tumors in 
adults but approximately 60% tumors in children.8 
The incidence of RMS is highest in children aged 
1–4 years, lower in children aged 10–14 years, and 
lowest in those aged 15–19 years.5,6 Our patient 
was 13 years old and did not fall in the very high-
risk category.
The head and neck region is the most common 
site for RMS, with the orbit being the most fre-
quent primary site. The most common site of in-
volvement in the oral cavity is the tongue followed 
by the soft palate, hard palate, and buccal muco-
sa.9 In our patient, the buccal mucosa, mandibular 
alveolar ridges, and hard palate were all involved. 
The soft tissue was more damaged than the bone, 
suggesting that the tumor primarily originated in 
the buccal mucosa. 
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In general, most patients have an advanced 
disease even at the stage of initial presentation 
because RMSs are known to show rapid growth 
and the patients generally tend to delay medical 
consultation.5,6 In our case, when the patient pre-
sented at our clinic, she had severe facial asym-
metry and experienced difficulty in opening the 
mouth. In cases of RMS, radiographic examination 
reveals the size of the lesion, space relation, and 
the extent of bone destruction, while MRI reveals 
the affected areas such as the mandible, condyle, 
maxillary sinus, and infra-orbitary space.
A careful histological examination is required 
to differentiate such lesions from other more fre-
quent and aggressive lesions affecting the con-
cerned site. In our case, the marked pleomor-
phism noted was critical for differentiating RMS 
from Ewing’s sarcoma. The presence of an alveo-
lar pattern, pleomorphism, cohesive nature of the 
cells, and the absence of lymphadenopathy ruled 
out the diagnosis of lymphoma. In this respect, the 
most critical differential diagnosis is neuroblas-
toma. A diffuse pattern of small round cells and 
the presence of rosettes/pseudorosettes with pale 
eosinophilic material seen in cases of neuroblas-
toma may suggest alveolar RMS. High level of uri-
nary catecholamines observed in neuroblastoma 
is critical to rule out this tumor.8,9  
Prognosis of RMS is relatively poor compared to 
that of other oral soft tissue malignant lesions10,11 
and depends on the clinical staging and the ana-
tomic site of the tumor.10 An early and accurate 
Figure 1. Intraoral aspect showing extensive mass involving the buccal mucosa.
Figure 3. Photomicrograph showing a sheet of mesenchymal cells in a myxoid stro-
ma (Hemotoxylin/Eosin (H/E) x200).
Figure 2. Magnetic Resonance Imaging (MRI) scan showing an infiltrative large soft 
tissue lesion in the maxillary sinus, infra-orbitary space, pterygopalatine fossa, 
pterygoid plates, and the ramus causing displacement of the adjacent structures.
Figure 4. Positive immunohistochemical staining for muscle specific-actin (strep-
tavidin biotin x200).
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diagnosis of the tumor and a combined therapeu-
tic approach involving surgery, chemotherapy, 
and radiation therapy are known to dramatically 
improve the survival rates, as seen in cases re-
corded over the past 20 years.8 Effective surgical 
excision is challenging in cases of RMS of the head 
or neck region owing to the involvement of other 
crucial structures in these locations. Therefore, 
we planned a multidisciplinary approach with in-
duction chemotherapy and radiotherapy to bring 
about tumor regression in our patient. Although 
the tumor showed a dramatic shrinkage after the 
initial 12 weeks of chemotherapy, the patient’s 
parents refused external beam radiation therapy. 
However, 6 months later, when the patient recon-
sulted at the Oncology Department for a recurrent 
lesion, she was administered further chemothera-
py and radiation therapy. Unfortunately, the tumor 
increased in size despite the treatments, and she 
died 2 years after the initial treatment.
Although a marked improvement in the sur-
vival rates has been reported in patients with RMS 
in recent years, a poor prognosis in patients >10 
years old, delay diagnosis, and lack of coopera-
tion from the patient and the family are reported 
to have a negative impact on the prognosis, as in 
our case.
Dental practitioners frequently encounter 
cases of children with facial swelling and pain; 
in most of these cases, dental abscess is consid-
ered as the cause and treatment is prescribed 
accordingly. Taken together, we conclude that in 
children, any swelling should be carefully exam-
ined and treatment outcomes should be regularly 
followed up. High degree of suspicion, early diag-
nosis, and a multidisciplinary treatment approach 
would be of great importance in such cases.
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